ArticleFrontiers in oncology2025

Downregulation of SALL1 and its association with poor prognosis and the immune cell landscape in clear cell renal cell carcinoma.

Gen-Yi Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.